Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Triple-negative breast cancer: understanding Wnt signaling in drug resistance, Cancer Cell International
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer, Experimental Hematology & Oncology
Multi-omics analysis identifies therapeutic vulnerabilities in
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
Cancers, Free Full-Text
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors [PeerJ]
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Cancers, Free Full-Text
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
Cancers, Free Full-Text